Company
ArunA Biomedical
Unlocking new possibilities for millions with neurological disease
Also known as Aruna Bio, Inc
- Business model
- B2B
- Legal name
- Aruna Bio, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
ArunA Biomedical is advancing a new class of cell-free biologics, exosomes, to treat neurodegenerative disorders. ArunA Bio also works with partners to use exosomes to optimize the delivery of RNAs, antibodies, genes and small molecules. ArunA Bio’s exosomes have demonstrated the ability to be safely administered intravenously in multiple doses with no adverse side effects and cross the blood-brain barrier to reach a site of injury. They’ve also been shown to reduce inflammation and enhance neural function.
Funding snapshot
- Total raised
- $22.4MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $13.3M2019-07-19
Funding rounds
- Round, 2019
- $13.3M2019-07-19, SEC form D sold, 81 investors
- Round, 2018
- $5.4M2018-07-07, SEC form D sold, 32 investors
- Round, 2016
- $3.7M2016-08-10, SEC form D sold, 14 investors
Loading relationship preview